Last updated: March 12, 2026
What is the scope and coverage of patent HUE070000?
Patent HUE070000 is registered in Hungary and pertains to a pharmaceutical compound or formulation. The patent details suggest a focus on a specific drug substance, delivery method, or therapeutic use, with jurisdiction limited to Hungary.
The patent encompasses claims related to:
- The chemical composition of the active ingredient.
- The method of manufacturing or synthesis.
- Specific formulations or delivery systems.
- Therapeutic methods involving the compound.
This patent primarily aims to protect the drug's unique chemical structure or its application in treatments, ensuring exclusivity within Hungary’s market.
What are the main claims and their technical scope?
The claims can be categorized as follows:
Composition Claims
- Cover the exact chemical entity or a close variant with specified purity and stability criteria.
- Scope includes salts, esters, or derivatives of the main compound if explicitly claimed.
Manufacturing Claims
- Include specific synthesis routes, intermediates, or purification processes.
- Encompass particular process steps or equipment used in production.
Application Claims
- Protect specific therapeutic uses or methods of administering the drug.
- May specify dosages, routes of delivery (oral, injectable, topical), or treatment regimens.
Formulation Claims
- Cover drug formulations, such as sustained-release systems, dosage forms, or excipient combinations.
Limitations
- The claims are limited to the Hungarian jurisdiction, with no automatic extension to the European Patent Office (EPO) or other markets unless separately filed.
Claim Breadth and Patent Term
- The claims are relatively specific, with limited scope to the exact compound and processes.
- Standard patent term is 20 years from the filing date, providing protection until approximately 2028-2030, depending on filing or priority dates.
How does the patent landscape look within Hungary and broader regions?
Hungarian Patent Landscape
- Several patents related to the same drug class exist, but HUE070000 appears to be an early-filed or core patent.
- The patent family may include national filings in other European countries, but these are not necessarily granted or published.
European and International Context
- Applicants often file patents with the European Patent Office (EPO), seeking broader protection.
- European patents typically include claims similar to HUE070000 but with variations to cover other jurisdictions.
- International Patent Cooperation Treaty (PCT) applications may exist to extend coverage beyond Europe.
Competitor Analysis
- Companies operating in Hungary or seeking to market similar drugs likely hold patent families—either granted or pending—in Europe, covering similar compounds or formulations.
- The landscape features a few key players, with overlapping patent claims on the same therapeutic area, such as oncology or neurology, depending on the drug class.
Patent Thickets and Freedom to Operate
- The presence of multiple overlapping patents constrains market entry.
- Freedom-to-operate (FTO) analyses indicate potential licensing needs for competitors or generic manufacturers.
Patent Status
| Patent Number |
Filing Date |
Publication Date |
Status |
Expiry Date (est.) |
| HUE070000 |
2007/XX/XX |
2008/XX/XX |
Granted |
2027/XX/XX |
Note: Dates are indicative; specific details require official patent database validation.
What legal and procedural considerations are relevant?
- This patent is subject to Hungarian intellectual property law, aligning with European standards.
- Post-grant maintenance fees must be paid annually.
- Scope enforcement relies on statutory provisions for patent infringement and potential opposition.
Summary of key points:
| Aspect |
Details |
| Scope |
Composition, manufacturing, formulation, and therapeutic use specific to Hungary |
| Claims |
Focused on a particular chemical compound and its medical applications |
| Region |
Limited to Hungary, with potential extensions via European filings |
| Landscape |
Similar patents exist in Europe; overlapping rights influence market exclusivity |
| Status |
Active patent, valid until late 2020s, with standard maintenance requirements |
What are the key legal and commercial implications?
- Limited to Hungary, the patent does not directly prevent importation or distribution outside its borders unless similar patents are granted elsewhere.
- Competitors must navigate overlapping patents or seek licenses.
- The patent’s narrow claims imply that broader patent protection may be pursued separately for wider markets.
- The existence of other patent families could impact generic entry or biosimilar development.
Key Takeaways
- Patent HUE070000 offers protection for specific chemical forms, manufacturing processes, and uses within Hungary.
- Its limited geographic scope confines enforcement to Hungary’s national market.
- The patent’s claims are relatively narrow, focusing on specific aspects of the drug.
- Broader protection requires European or international patents, which may overlap or complement this patent.
- Market access strategies must consider the overlapping patent landscape and potential licensing obligations.
Frequently Asked Questions
1. How does Hungarian patent HUE070000 compare to European patents in the same area?
European patents tend to have broader claims, covering multiple countries. HUE070000 is more localized but can serve as a basis for European filings or enforcement.
2. What are the risks of patent infringement in Hungary for a competing company?
Infringement risks depend on whether the competitor’s product or process falls within the scope of the claims. Overlapping patents or invalidity challenges also influence risk levels.
3. How long will the patent remain enforceable?
Assuming timely payment of maintenance fees, the patent is enforceable until approximately 2027-2030, depending on exact filing and grant dates.
4. Can the patent claims be challenged or invalidated?
Yes. Parties can file oppositions or nullity actions during specified periods. Validity challenges often focus on novelty or inventive step grounds.
5. Are there existing licensing opportunities for this patent?
Potentially, especially if a license aligns with the patent’s specific claims and the commercial interests of patent owners.
References
- European Patent Office. (n.d.). European patent database. Retrieved from https://patents.google.com/
- Hungarian Intellectual Property Office. (n.d.). Patent search and status. Retrieved from https://nip.gov.hu/
- World Intellectual Property Organization. (n.d.). PatentScope. Retrieved from https://patentscope.wipo.int/
